Translate into a different language

Wednesday, May 16, 2018

Find out about Machine Learning, Artificial Intelligence, Big Data and Patient Engagement at FutureLink Munich | pharmaceutical - Packaging Europe

TraceLink Inc., the Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, has announced the latest keynote speakers for its upcoming FutureLink Munich conference to be held June 5-7, 2018. 


Confirmed speakers include industry and academic thought-leaders: Professor Elgar Fleisch, Ph.D., of ETH Zurich; Justus Wolff of the Syte Institute; and, Andrew Rut, M.D., CEO, MyMeds&Me.

FutureLink Munich Addresses Artificial Intelligence, Machine Learning and Patient Engagement The unique FutureLink value track will address the operational and commercial challenges in the pharmaceutical and healthcare arenas, delivering industry insights on how to capitalize on serialization and big data with artificial intelligence (AI), machine learning and predictive analytics, to improve patient outcomes. The conference will include discussions and workshops for commercial executives interested developing transformative strategies for brand protection, patient safety, instant and accurate product recalls and directly engaging healthcare providers at the point-of-dispense, and with patients at the point of consumption. 

Featured value speakers at FutureLink Munich include: 
•    Professor Elgar Fleisch, Ph.D. from ETH Zurich and the University of St. Gallen, will cover the application of artificial intelligence (AI) and machine learning in the pharmaceutical and healthcare fields in his presentation, “The Digital Pill: How Digital Technologies Change Health Care.”...

FutureLink Munich is being held at the Sheraton Munich Arabellapark Hotel. 
For further information and to register for the conference, visit https://www.tracelink.com/futurelink-munich/about
Read more...  

Source: Packaging Europe


If you enjoyed this post, make sure you subscribe to my Email Updates!

0 comments: